Biotinylated Anti-Human GRO-α/MGSA (CXCL1) 0 评论Submit a Review 产品详情 产品编号： 500-P92BT 产品描述： Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human GRO-alpha/MGSA (CXCL1). Anti-Human GRO-alpha/MGSA (CXCL1)-specific antibody was purified by affinity chromatography and then biotinylated. Immunogen: E.coli derived Recombinant Human GRO-α/MGSA (CXCL1) (PeproTech catalog# 300-11) Sandwich ELISA: To detect Human GRO-α/MGSA by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human GRO-α/MGSA (500-P92) as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant Human GRO-α/MGSA. Western Blot: To detect Human GRO-α/MGSA by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant Human GRO-α/MGSA is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. Note: 1mg will be provided as 2x500μg. crossreactivity: Human References SDS CoA 搜索 Product Line Country Of Origin: USA Not for human use. Research Interest 血管生成/心血管 化学趋化 炎症 神经生物学 创伤修复 product.subtitle.recentcitations 第一作者 Bouhaddou, M 标题 The Global Phosphorylation Landscape of SARS-CoV-2 Infection. 文献引用 Cell; 182(3) pg685-712.e19 PubMed Id 32645325 第一作者 Øynebråten, I 标题 Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol. 文献引用 Journal of immunology (Baltimore, Md. : 1950); 175(8) pg5358-69 PubMed Id 16210642
